Alcon Financial Statements From 2010 to 2025

ALC Stock  USD 90.12  1.99  2.26%   
Alcon AG's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Alcon AG's valuation are provided below:
Alcon AG does not presently have any fundamental signals for analysis.
Check Alcon AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alcon AG's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alcon financial statements analysis is a perfect complement when working with Alcon AG Valuation or Volatility modules.
Check out the analysis of Alcon AG Correlation against competitors.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.

Alcon AG Company Current Valuation Analysis

Alcon AG's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Alcon AG Current Valuation

    
  47.64 B  
Most of Alcon AG's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alcon AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Alcon AG has a Current Valuation of 47.64 B. This is 231.67% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 186.57% lower than that of the firm.

Alcon AG Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alcon AG's current stock value. Our valuation model uses many indicators to compare Alcon AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alcon AG competition to find correlations between indicators driving Alcon AG's intrinsic value. More Info.
Alcon AG is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.52  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Alcon AG is roughly  1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alcon AG's earnings, one of the primary drivers of an investment's value.

About Alcon AG Financial Statements

Alcon AG stakeholders use historical fundamental indicators, such as Alcon AG's revenue or net income, to determine how well the company is positioned to perform in the future. Although Alcon AG investors may analyze each financial statement separately, they are all interrelated. For example, changes in Alcon AG's assets and liabilities are reflected in the revenues and expenses on Alcon AG's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Alcon AG. Please read more on our technical analysis and fundamental analysis pages.
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 24000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Alcon AG offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alcon AG's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alcon Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alcon Ag Stock:
Check out the analysis of Alcon AG Correlation against competitors.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.